权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Animal Models Core

动物模型核心

基本信息

批准号：
8379857
负责人：
G IAN GALLICANO
金额：
$ 16.59万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/8379857
关键词：
Animal Model Animals Antineoplastic Agents Archives Biological Assay Breeding Cancer Patient Caring Cataloging Catalogs Cell Separation Cells Clinical Clinical Research Computer software Coupled Cryopreservation Data Databases Embryo Ensure Equipment Excision Fetus Fibroblasts Freezing Genetic Genotype Growth Health Housing Human Image Immunity Individual Injection of therapeutic agent Intestinal Cancer Knock-out Knockout Mice Liquid substance Location Longitudinal Studies Malignant Neoplasms Malignant neoplasm of gastrointestinal tract Malignant neoplasm of large intestine Medical Genetics Mission Modeling Molecular Mus Nitrogen Nude Mice Online Systems Operating Rooms Operative Surgical Procedures Outcome Pancreas Partner in relationship Patients Pharmaceutical Preparations Pharmacotherapy Predisposition Primitive foregut structure Printing Production Publishing Reaction Records Research Research Personnel Research Project Grants Resolution Role Running Sampling Schedule Services Site Small Intestines Sorting - Cell Movement Source Specific Pathogen Frees Stomach Testing Tissues Transgenic Mice Transgenic Model Transgenic Organisms Translational Research Tumor Tissue Ultrasonography Universities Work Xenograft procedure blastocyst chemotherapeutic agent cost efficacy testing embryonic stem cell germ free condition in vivo malignant stomach neoplasm member mouse model mutant neoplastic cell offspring programs pup sperm cell tissue preparation tumor

项目摘要

The Animal Models Core (AMC) will support all of the research projects in the program by providing the necessary genetically modified mice and producing low-passage in vivo human gastro-intestinal cancer explants in mice. One mission of the AMC will be to maintain mice for long-term studies to evaluate predisposition to cancer. A second mission of the AMC will be maintaining stocks of the genetically modified strains (e.g., elf, eif/Smad4, Smad4, Smad3, Cdk4-R24C mutant, cdk4 null mutant, htert knockout), and to breed these strains together to produce fetuses of double and triple mutant homozygous genotypes. Working with the Tissue Core B, these fetuses will be used as a source of embryonic fibroblasts and tumor cells by the projects. Pups with the desired double or triple mutant genotypes will constitute a large fraction of the progeny. To provide a continuous supply in support of the research projects a large amount of breeding, coupled with genotype analysis to identify the appropriate individuals will be required. A third mission of the AMC will be to provide synergy between the clinicians and projects testing anti-cancer drug therapies. This synergy will be in the form of producing, and providing husbandry of mice harboring genetic backgrounds predisposed to making tumors or nude mice xenografted with human tumor tissues for propagating lowpassage tumors. All mice will be produced and housed under barrier conditions that ensure continuing specific pathogen free status, Centralization of the production and care of these mice under the AMC will limit the number of individuals handling the animals, thereby further safeguarding their health. Moreover, by centralizing the production and dispensation of these genetically valuable animals, the animal core will be able to coordinate usage among the different projects, avoid wastage, and achieve an economy of scale that will permit these studies to be completed at less expense than if undertaken separately. A final mission of the AMC will be to serve as a synergistic hub for all projects and cores.

动物模型核心（AMC）将为该计划中的所有研究项目提供支持